Clinical trial · Interventional
Comparison of D2 vs D3 Lymph Node Dissection for Right Colon Cancer (RICON)
NCT03200834CI-TRIAL-00087708active not recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Comparing different method of surgical technique D2 lymph node dissection vs D3 for right colon cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Right Hemicolectomy with D2 lymph node dissection | Procedure | — | UNRESOLVED |
| Right Hemicolectomy with D3 lymph node dissection | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- D2 lymph node dissection for right colon cancer
- description
- Hemicolectomy for right colon cancer with D2 lymph node dissection
- interventionNames
- Procedure: Right Hemicolectomy with D2 lymph node dissection
- type
- EXPERIMENTAL
- label
- D3 lymph node dissection for right colon cancer
- description
- Hemicolectomy for right colon cancer with D3 lymph node dissection
- interventionNames
- Procedure: Right Hemicolectomy with D3 lymph node dissection
Primary outcomes (1)
- measure
- 5-year survival
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: 1. Agreement of the patient to participate in trial 2. Colon cancer (only adenocarcinoma ) 3. The tumor located between the cecum and the right 1/3 of transverse colon 4. Tumors T3,Т4а,b N0-2 (II-III stages) 5. Tolerance of chemotherapy 6. ECOG 0-2 Exclusion Criteria: 1. Patients with distant metastases 2. Tumors T1-2 (I stage) 3. Complications of tumor (perforation and full bowel obstruction) 4. Previous radiotherapy or chemotherapy 5. Synchronous or metachronous tumors 6. Women during Pregnancy or breast feeding period
References
Publications (1)
- DERIVEDBalaban V, Mutyk M, Bondarenko N, Zolotukhin S, Sovpel O, Sovpel I, Zykov D, Rublevskiy I, Klochkov M, Prado AP, He M, Tsarkov P. Comparison of D2 vs D3 lymph node dissection for RIght COloN cancer (RICON): study protocol for an international multicenter open-label randomized controlled trial. Trials. 2024 Jul 2;25(1):438. doi: 10.1186/s13063-024-08269-5. PMID 38956698